Single dose typhoid conjugate vaccine provides — Feat

A single dose of the typhoid conjugate vaccine, Typbar TCV®, provides lasting efficacy in preventing typhoid fever in children ages 9 months to 12 years old,

Related Keywords

Hyderabad , Andhra Pradesh , India , Malawi , Bharat , Myronm Levine , Akikok Bowers , Markt Gladwin , Kathleen Neuzil , Liverpool Wellcome Trust , Vaccine Development , Clinical Research Programme , University Of Maryland School Medicine , Bharat Biotech International , University Of Maryland , Melinda Gates Foundation , Global Health , Maryland School , Malawi Liverpool Wellcome Trust , Clinical Research , Saharan Africa , Vice President , Medical Affairs , Melinda Gates , Bharat Biotech International Limited , Children , Asting Efficacy , Ypbar Tcv , Typhoid Conjugate Vaccine ,